Physician profile
Claire Reddick
NPI 1689870735
$12,083.46
in general payments reported to CMS, 2019-2025
43 companies · $1,952 in 2025
The $1,952 reported for 2025 was more than what 75% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,300 · 2020: $1,165 · 2021: $1,607 · 2022: $2,022 · 2023: $2,037 · 2024: $2,000 · 2025: $1,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,889 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,888.72 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,271.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,242.79 | 2019-2025 | |
| Galderma Laboratories, L.P. | $1,198.04 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Regeneron Healthcare Solutions, INC. | $1,013.48 | 2020-2025 | Dupixent, Libtayo |
| Lilly USA, LLC | $848.40 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $698.74 | 2019-2025 | Tremfya |
| Genzyme Corporation | $613.31 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $609.87 | 2019-2025 | Winlevi |
| Leo Pharma INC. | $564.62 | 2019-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $328.35 | 2023-2025 | Zoryve |
| Pfizer INC. | $313.49 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $228.54 | 2021-2025 | |
| Incyte Corporation | $221.53 | 2022-2025 | Opzelura |
| Allergan, INC. | $206.50 | 2019-2022 | |
| Almirall LLC | $188.98 | 2019-2025 | Klisyri, Seysara |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Claire Reddick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.